Proton therapy in clinical practice

Radiation dose escalation and acceleration improves local control but also increases toxicity. Proton radiation is an emerging therapy for localized cancers that is being sought with increasing frequency by patients. Compared with photon therapy, proton therapy spares more critical structures due to its unique physics. The physical properties of a proton beam make it ideal for clinical applications. By modulating the Bragg peak of protons in energy and time, a conformal radiation dose with or without intensity modulation can be delivered to the target while sparing the surrounding normal tissues. Thus, proton therapy is ideal when organ preservation is a priority. However, protons are more sensitive to organ motion and anatomy changes compared with photons. In this article, we review practical issues of proton therapy, describe its image-guided treatment planning and delivery, discuss clinical outcome for cancer patients, and suggest challenges and the future development of proton therapy.

[1]  T. Hashimoto,et al.  Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. , 2011, International journal of radiation oncology, biology, physics.

[2]  H. Satoh,et al.  Proton beam therapy of Stage II and III non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[3]  K. Nihei,et al.  Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. , 2011, International journal of radiation oncology, biology, physics.

[4]  Devanshi Dinesh Mayani Proton therapy for cancer treatment , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[5]  Radhe Mohan,et al.  Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[6]  M. Ikeda,et al.  Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[7]  Johannes A Langendijk,et al.  Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. , 2011, International journal of radiation oncology, biology, physics.

[8]  Joe Y. Chang,et al.  Adaptive Radiation for Lung Cancer , 2010, Journal of oncology.

[9]  A. Trofimov,et al.  Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. , 2009, International journal of radiation oncology, biology, physics.

[10]  R. Mohan,et al.  Proton Therapy Targets Cancer Stem Cells in Treatment-resistant Non-small Cell Lung Cancer , 2010 .

[11]  Shinji Sugahara,et al.  Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba. , 2010, International journal of radiation oncology, biology, physics.

[12]  Joe Y. Chang,et al.  Improving radiation conformality in the treatment of non-small cell lung cancer. , 2010, Seminars in radiation oncology.

[13]  Radhe Mohan,et al.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. , 2010, International journal of radiation oncology, biology, physics.

[14]  Andrzej Niemierko,et al.  Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. , 2010, JAMA.

[15]  M. Tokita,et al.  Proton beam therapy for large hepatocellular carcinoma. , 2010, International journal of radiation oncology, biology, physics.

[16]  H. Sakurai,et al.  Proton beam therapy for hepatocellular carcinoma , 2009, Cancer.

[17]  D. Yeung,et al.  Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[18]  Radhe Mohan,et al.  The M. D. Anderson proton therapy system. , 2009, Medical physics.

[19]  Joao Seco,et al.  Breathing interplay effects during proton beam scanning: simulation and statistical analysis , 2009, Physics in medicine and biology.

[20]  T. Merchant Proton Beam Therapy in Pediatric Oncology , 2009, Cancer journal.

[21]  N. Fukumitsu,et al.  A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[22]  M Engelsman,et al.  Commissioning a passive-scattering proton therapy nozzle for accurate SOBP delivery. , 2009, Medical physics.

[23]  D. Yeung,et al.  Proton Therapy for Maxillary Sinus Carcinoma , 2009, American journal of clinical oncology.

[24]  J. Semenova Proton Beam Radiation Therapy in the Treatment of Pediatric Central Nervous System Malignancies: A Review of the Literature , 2009, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[25]  N. Tarbell,et al.  A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. , 2009, International journal of radiation oncology, biology, physics.

[26]  A. Pérez-Andújar,et al.  Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system , 2009, Physics in medicine and biology.

[27]  Roberto Orecchia,et al.  Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. , 2009, Cancer treatment reviews.

[28]  Riccardo Calandrino,et al.  Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. , 2008, International journal of radiation oncology, biology, physics.

[29]  A. Chan,et al.  Proton radiation therapy for head and neck cancer , 2008, Journal of surgical oncology.

[30]  T. Hashimoto,et al.  Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. , 2007, International journal of radiation oncology, biology, physics.

[31]  Dirk De Ruysscher,et al.  Proton therapy in clinical practice: current clinical evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Joe Y. Chang,et al.  4D Proton treatment planning strategy for mobile lung tumors. , 2007, International journal of radiation oncology, biology, physics.

[33]  M. Bussière,et al.  Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Radhe Mohan,et al.  Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[35]  K. Nihei,et al.  High-dose proton beam therapy for Stage I non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[36]  Eike Rietzel,et al.  Four-dimensional proton treatment planning for lung tumors. , 2006, International journal of radiation oncology, biology, physics.

[37]  I. Gibbs,et al.  Role of radiation therapy in pediatric cancer. , 2006, Hematology/oncology clinics of North America.

[38]  Alfred R. Smith,et al.  Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? , 2005, International journal of radiation oncology, biology, physics.

[39]  Daniel W. Miller,et al.  Hypofractionated proton beam radiotherapy for stage I lung cancer. , 2004, Chest.

[40]  A. Zietman,et al.  10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study. , 2004, The Journal of urology.

[41]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[42]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  A. Ruifrok,et al.  Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses. , 2000, International journal of radiation oncology, biology, physics.

[44]  L. Gerweck,et al.  Relative biological effectiveness of proton beams in clinical therapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  P L Petti,et al.  New compensator design options for charged-particle radiotherapy. , 1997, Physics in medicine and biology.

[46]  J. Fowler,et al.  New approaches to radiation therapy in locally advanced carcinoma of the cervix. , 1994, Seminars in oncology.

[47]  H. Tsujii,et al.  Clinical results of fractionated proton therapy. , 1993, International journal of radiation oncology, biology, physics.

[48]  J M Slater,et al.  The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. , 1992, International journal of radiation oncology, biology, physics.

[49]  The potential for proton beam therapy in locally advanced carcinoma of the cervix. , 1992, International journal of radiation oncology, biology, physics.

[50]  B. Smit Prospects for proton therapy in carcinoma of the cervix. , 1992, International journal of radiation oncology, biology, physics.

[51]  C. V. Levin,et al.  Potential for gain in the use of proton beam boost to the para-aortic lymph nodes in carcinoma of the cervix. , 1992, International journal of radiation oncology, biology, physics.

[52]  M Goitein,et al.  Planning proton therapy of the eye. , 1983, Medical physics.

[53]  L. Verhey,et al.  Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy. , 1982, International journal of radiation oncology, biology, physics.

[54]  T Kanai,et al.  Spot scanning system for proton radiotherapy. , 1980, Medical physics.

[55]  M. Raju A heavy particle comparative study Part III : OER and RBE , 1979 .

[56]  R. A. Cox,et al.  A heavy particle comparative study. Part III: OER and RBE. , 1978, The British journal of radiology.

[57]  A. Frantz,et al.  Proton-beam therapy in acromegaly. , 1968, The New England journal of medicine.

[58]  S. Falkmer,et al.  Pilot Study on Proton Irradiation of Human Carcinoma , 1962 .

[59]  S. Falkmer,et al.  Pilot study on proton irradiation of human carcinoma. , 1962, Acta radiologica.

[60]  J H LAWRENCE,et al.  Pituitary irradiation with high-energy proton beams: a preliminary report. , 1958, Cancer research.

[61]  R. Wilson Radiological use of fast protons. , 1946, Radiology.

[62]  W. Bragg,et al.  LXXIV. On the ionization curves of radium , 1904 .